MDM2 and non-functioning pituitary adenoma: In this study we used TMAs to evaluate the expression of HMGA1, Ki-67, MDM2, and RB in 35 paired NFPA cases of primary and recurrent/regrowth tumors to identify a suitable marker for NFPA progression.